News

2021 Jul 28

Cancer Vaccine Improves Outcomes in Lynch Syndrome Model

A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital. The preclinical results... Read more

2021 Jul 16

Dr. Pinkal Desai's Phase 2 Trial Shows Cell Therapy May Prevent Infections in Leukemia Patients

Treatment with a ready-made preparation of human immune cells helps prevent infections in people whose immune systems are temporarily weakened by leukemia treatment, according to a phase 2 clinical trial led by researchers... Read more

2021 Jul 01

Research Suggests How Tumors Evolve to Become Aggressive Form of Prostate Cancer

Single-cell RNA sequencing of prostate cells from mice with alterations in Pten, RB1 and MYCN identified 10 major cell subtypes and enabled researchers to study tumor heterogeneity with unprecedented resolution. Credit: Dr... Read more

2021 Jun 24

MCC Member & C2i Genomics Co-Founder Dan Landau's Achievement - C2i Genomics Named Finalist for Nature’s Spinoff Prize

Early cancer detection can make all the difference for a patient. Yet many cancers aren’t diagnosed until it’s too late. Drs. Dan Landau and Asaf Zviran are working to develop ultra-sensitive blood tests – called “liquid... Read more

2021 Jun 21

Identifying Social Determinants of Health in Brooklyn

A study from researchers at NewYork-Presbyterian and Weill Cornell Medicine identified economic and social conditions impacting individual and group differences in health status, known as social determinants of health, in... Read more

Radiologist examining a chest X-ray of a patient. Credit: Shutterstock

2021 Jun 15

Combination Therapy Boosts Lung Cancer Patients’ Response, Cuts Treatment Time in Phase 2 Trial

Combining immunotherapy with targeted radiation resulted in a greater response rate than immunotherapy alone in a phase 2 clinical trial in patients with early-stage, non-small-cell lung cancer led by Weill Cornell Medicine... Read more

2021 Jun 09

Breast Cancer Risk in African Americans Tied to Genetic Variations

Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and... Read more

2021 May 28

Two Meyer Cancer Center Investigators Win Pershing Square Sohn Prize for Cancer Research

Dr. Marcin Imielinski , an assistant professor of pathology and laboratory medicine, and Dr. Elena Piskounova , an assistant professor of cell biology in dermatology, both at Weill Cornell Medicine, were awarded the 2021... Read more

2021 May 17

Scientists Gain Insight into the Mechanisms of Fat Burning and Storage

A new understanding of the interaction of two proteins and their role in fat burning and storage may one day have implications for the treatment of obesity and associated diseases such as diabetes and cancer, according to... Read more

Photo of Christopher Barbieri, M.D., Ph.D.

2021 May 17

Molecular Characterization Can Help Predict How Prostate Cancer Will Behave

Molecular characteristics detected in prostate cancers can provide clues that help predict how the disease will progress, according to new research from investigators at Weill Cornell Medicine and NewYork-Presbyterian. The... Read more

2021 May 10

Dr. Dan Landau's Study New Mapping Technique Reveals Epigenetic Drivers of Cancers

Scientists have made major advances in understanding and developing treatments for many cancers by identifying genetic mutations that drive the disease. Now a team led by researchers at Weill Cornell Medicine, NewYork-... Read more

2021 May 06

Two Grants Aim to Increase Access to Care and Clinical Trials for Queens and Brooklyn Patients with Blood Cancers

Weill Cornell Medicine has received complementary grants from Genentech and the Leukemia & Lymphoma Society (LLS) to support a new program that aims to address socioeconomic and racial disparities and increase access to... Read more

2021 Apr 27

Dr. Erica Phillips's Inaugural Marie Metoyer Award: WCM 2021 Pioneers in Diversity Awards

Weill Cornell Medicine honored more than two dozen faculty, trainees, students and staff April 26 for their outstanding service and leadership in promoting diversity at the academic medical institution. The annual Diversity... Read more

2021 Apr 26

Low Income Drives Financial Stress, Cancer-Related Worry and Anxiety Among Women with Gynecologic Cancers During Pandemic

Patients with gynecologic cancers who have Medicaid coverage are more likely to feel increased financial distress, anxiety about their cancer and increased general anxiety during the pandemic if their annual income is less... Read more

2021 Apr 23

Dr. David Lyden's Induction into Association of American Physicians

Weill Cornell Medicine physician-scientist Dr. David Lyden , whose research has led to groundbreaking discoveries about how cancer spreads, has been elected into the esteemed Association of American Physicians. Dr. Lyden,... Read more

Cancer immunologist Sandra Demaria, M.D., of the Meyer Cancer Center, is using radiation to transform tumors into personalized vaccines

2021 Mar 26

Study in Mice Suggests Radiation Therapy May Be an Important Addition to Personalized Vaccination for Cancer

Radiation therapy appears to increase or upregulate the expression of genes with mutations that induce an immune response to malignant cells, according to preclinical research by Weill Cornell Medicine and NewYork-... Read more

2021 Mar 22

Apostolou Lab's Study: Understanding and Exploiting “Cell Identity Crisis” Provides Potential New Routes to Stem Cell Therapy, Cancer Treatment

Molecular "bookmarks," which allow cells to retain their characteristics during cell division, ensure fast reactivation of critical cell identity genes after cell division, according to investigators at Weill Cornell... Read more

2021 Mar 12

Cancer Vaccine Improves Outcomes in Lynch Syndrome Model

Dr. Pinkal Desai's Phase 2 Trial Shows Cell Therapy May Prevent Infections in Leukemia Patients

Research Suggests How Tumors Evolve to Become Aggressive Form of Prostate Cancer

MCC Member & C2i Genomics Co-Founder Dan Landau's Achievement - C2i Genomics Named Finalist for Nature’s Spinoff Prize

Identifying Social Determinants of Health in Brooklyn

Combination Therapy Boosts Lung Cancer Patients’ Response, Cuts Treatment Time in Phase 2 Trial

Breast Cancer Risk in African Americans Tied to Genetic Variations

Two Meyer Cancer Center Investigators Win Pershing Square Sohn Prize for Cancer Research

Scientists Gain Insight into the Mechanisms of Fat Burning and Storage

Molecular Characterization Can Help Predict How Prostate Cancer Will Behave

Dr. Dan Landau's Study New Mapping Technique Reveals Epigenetic Drivers of Cancers

Two Grants Aim to Increase Access to Care and Clinical Trials for Queens and Brooklyn Patients with Blood Cancers

Dr. Erica Phillips's Inaugural Marie Metoyer Award: WCM 2021 Pioneers in Diversity Awards

Low Income Drives Financial Stress, Cancer-Related Worry and Anxiety Among Women with Gynecologic Cancers During Pandemic

Dr. David Lyden's Induction into Association of American Physicians

Study in Mice Suggests Radiation Therapy May Be an Important Addition to Personalized Vaccination for Cancer

Apostolou Lab's Study: Understanding and Exploiting “Cell Identity Crisis” Provides Potential New Routes to Stem Cell Therapy, Cancer Treatment

Dr. Melnick's Study Finds Cancer Cells May Evade Chemotherapy by Going Dormant

Landau Lab's Super-Sensitive Cancer Blood Test Earns “Top 10” Award from Clinical Research Forum

Dr. Cerchietti's Findings - Tumor Microenvironment Seen as a New Player in Aggressive Lymphomas

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters